Schizophrenia studies

Comparative analysis of the effectiveness of clozapine in resistant schizophrenia and schizoafective disorder.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Spain

Sponsor

Fundación Hospital Provincial de Castellón

Effets du Fénofibrate durant la première année de schizophrénie (effects of Fenofibrate® in first year of schizophrenia)

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

France

Sponsor

Centre Hospitalier Régional et Universitaire de Lille

Efficacy and tolerability of Ziprasidone vs. Clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and cannabis use disorder: A randomised study

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Department of Psychiatry and Psychotherapy (Cologne)

Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Zentralinstitut für Seelische Gesundheit Mannheim

Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffer...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Klinikum Fulda gAG

Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN)

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Netherlands

Sponsor

AMC- academisch psychiatrisch centrum

Randomized, controlled trial of the effectiveness of add-on tolcapone to usual antipsychotic therapy on cognitive and negative symptoms of patients with schizophrenia genotyped for COMT polymorphisms

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Greece

Sponsor

MediPsych SA

Ventral striatal function in patients with schizophrenia before and under medication with atypical antipsychotics: a comparison of sertindole and risperidone

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich

A multidisciplinary study of the management of neuroleptic medication in schizophrenia: Educational and collaborative approaches

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Medical Research Council (MRC) (UK)

Acute effects of modafinil on cognitive function and activation of prefrontal cortex in people with schizophrenia

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Department of Health (UK)

An international study of improving treatment for the most severely ill with schizophrenia

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Department of Health (UK)

An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

France, Belgium, Austria, + 18 others

Sponsor

Boehringer Ingelheim